JBK HCT Tablet 5/40/12.5 mg

Adult dose

This medication should be taken once daily, with or without food, accompanied by water. It is recommended to take it at the same time each day (e.g., in the morning). The maximum dosage is 10/40/25 mg of Amlodipine/Olmesartan Medoxomil/Hydrochlorothiazide. Dosage adjustments should be made with intervals of at least 2 weeks, considering the blood pressure response. The dosage escalation schedule is as follows: 5/20/0 mg → 5/20/12.5 mg ↓

Child dose

Safety and efficacy have not been established for pediatric patients under 18 years of age, so administration is not recommended.

This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to this medication or similar drugs, those who are pregnant or breastfeeding, those with severe hypotension or heart disease, and those with severely impaired kidney or liver function should not take this medication. Patients with reduced blood volume or those dependent on kidney function may experience hypotension or worsening kidney function; thus, their condition should be closely monitored, and appropriate measures taken if necessary before taking this medication. This medication has a blood pressure-lowering effect, which may cause dizziness or light-headedness during treatment. Caution is advised when driving or operating dangerous machinery. This medication can affect potassium levels, so patients at risk of hyperkalemia or hypokalemia should regularly check their potassium levels through blood tests. In some patients, the skin may become sensitive to sunlight, leading to photosensitive reactions such as rashes or itching; therefore, sunlight exposure should be avoided, and consultation with a physician should be sought if symptoms occur. This medication can interact with various other drugs; hence, patient should inform their doctor or pharmacist if they are taking other medications. Safety and efficacy have not been established for patients under 18 years of age, so it is not recommended for this group. For elderly patients, there may be a decline in liver, kidney, and heart function, so they should start at a low dose and their condition should be monitored closely. In cases of overdose, symptoms such as hypotension, palpitations, and dizziness may appear, and immediate medical attention should be sought for appropriate treatment. This medication should be stored in a closed container, kept away from moisture, heat, and light, and out of reach of children.

Serious side effects

Hives, severe swelling, chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain of oral/ocular mucosa, difficulty in breathing or shortness of breath, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion of consciousness, visual disturbances, paralysis, decreased urine output

Mild side effects

• Peripheral edema
• headache
• dizziness
• upper respiratory infection
• rhinitis
• urinary tract infection
• sialadenitis
• leukopenia
• thrombocytopenia
• bone marrow suppression

This medication should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain the storage temperature between 1 degree and 30 degrees Celsius to preserve the medication's effectiveness and safety for a long duration.

Appearance

Pale yellow round film-coated tablet

Package unit

30 tablets (10 tablets/Alu-Alu × 3)